Massive study reveals COVID-19 risks for autoimmune patients
NCT ID NCT04353609
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at over 13,000 people with chronic inflammatory rheumatism or autoimmune diseases who had or were suspected to have COVID-19. Researchers tracked how many developed severe COVID-19 requiring intensive care or leading to death. They also examined risk factors like diabetes and obesity. The goal is to better understand and protect this vulnerable group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify which patients with autoimmune diseases are at highest risk for severe COVID-19, leading to better protection and care.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to all patient groups or future virus variants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTO-INFLAMMATORY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Huriez
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Could music be medicine for the injured brain?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can engineered immune cells tame autoimmune disease?
- Blood test may spot hidden nerve damage behind chronic constipation
- Can a simple blood test unlock the secrets of brain autoimmune diseases?